A serum circulating miRNA signature for short-term risk of progression to active tuberculosis among household contacts

Frontiers in Immunology

Volumn 9, Issue APR, 2018, Pages

  Duffy, Fergal J ^a   Thompson, Ethan ^a   Downing, Katrina ^b   Suliman, Sara ^b   Mayanja Kizza, Harriet ^c,d   Henry Boom, W ^e   Thiel, Bonnie ^e,l   Weiner, J ^f   Kaufmann, Stefan H E ^f   Dover, Drew ^a   Tabb, David L ^g   Dockrell, Hazel M ^h   Ottenhoff, Tom H M ⁱ   Tromp, Gerard ^g   Scriba, Thomas J ^b   Zak, Daniel E ^a   Walzl, Gerhard ^g,j   Parida, S K ^f   Golinski, R ^f   Maertzdorf, J ^f   Jacobson, M ^f   McEwen, G ^f   Black, G ^j   van der Spuy, G ^j   Stanley, K ^j   Kriel, M ^j   Du Plessis, N ^j   Nene, N ^j   Loxton, A ^j   Chegou, N N ^j   Mahomed, H ^b   Erasmus, M ^b   Xasa, O ^b   Veldsman, A ^b   Hughes, J ^b   Penn Nicholson, A ^b   Mulenga, H ^b   Abel, B ^b   Bowmaker, M ^b   Kagina, B ^b   Kwong, W C ^b   Hanekom, W ^b   Klein, M R ⁱ   Haks, M C ⁱ   Franken, K L ⁱ   Geluk, A ⁱ   van Meijgaarden, K E ⁱ   Joosten, S A ⁱ   van Baarle, D ^k   Miedema, F ^k   Boom, W H ^l   Sadoff, J ^m   Sizemore, D ^m   Ramachandran, S ^m   Barker, L ^m   Brennan, M ^m   Weichold, F ^m   Muller, S ^m   Geiter, L ^m   Schoolnik, G ⁿ   Dolganov, G ⁿ   Van, T ⁿ   Joloba, M ^c   Zalwango, S ^c   Nsereko, M ^c   Okwera, B ^c   Kisingo, H ^c   Smith, S ^h   Gorak Stolinska, P ^h   Hur, Y G ^h   Lalor, M ^h   Lee, J S ^h   Crampin, A C ^o   French, N ^o   Ngwira, B ^o   Smith, A B ^o   Watkins, K ^o   Ambrose, L ^o   Simukonda, F ^o   Mvula, H ^o   Chilongo, F ^o   Saul, J ^o   Branson, K ^o   Kassa, D ^p   Abebe, A ^p   Mesele, T ^p   Tegbaru, B ^p   Howe, R ^q   Mihret, A ^q   Aseffa, A ^q   Bekele, Y ^q   Iwnetu, R ^q   Tafesse, M ^q   Yamuah, L ^q   Ota, M ^r   Sutherland, J ^r   Hill, P ^r   Adegbola, R ^r   Corrah, T ^r   Antonio, M ^r   Togun, T ^r   Adetifa, I ^r   Donkor, S ^r   Andersen, P ^s   Rosenkrands, I ^s   Doherty, M ^s   Weldingh, K ^s   more..

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^g UNIVERSITY OF STELLENBOSCH   (South Africa)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j STELLENBOSCH UNIVERSITY   (South Africa)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m AERAS   (United States)

ⁿ STANFORD UNIVERSITY   (United States)

^o KARONGA PREVENTION STUDY   (Malawi)

^p ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^q ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^r Medical Research Council Unit   (Gambia)

^s STATENS SERUM INSTITUT   (Denmark)

more..

Author keywords

Biomarker; Correlate of risk; Household contact; Machine learning; MicroRNA; Tuberculosis

Indexed keywords

MICRORNA;

ALGORITHM; ARTICLE; HOUSEHOLD; HUMAN; MACHINE LEARNING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBERCULOSIS;

EID: 85045324159     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00661     Document Type: Article

References (27)

1. Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med (2016) 13:e1002152. doi:10.1371/journal.pmed.1002152
2. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis (2004) 8:392-402
3. Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis (2015) 211(Suppl 2):S21-8. doi:10.1093/infdis/jiu803
4. Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet (2016) 387:2312-22. doi:10.1016/S0140-6736(15)01316-1
5. Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem (2011) 67:129-39. doi:10.1007/s13105-010-0050-6
6. Mehta MD, Liu PT. MicroRNAs in mycobacterial disease: friend or foe? Front Genet (2014) 5:231. doi:10.3389/fgene.2014.00231
7. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 108:5003-8. doi:10.1073/pnas.1019055108
8. Correia CN, Nalpas NC, Mcloughlin KE, Browne JA, Gordon SV, Machugh DE, et al. Circulating microRNAs as potential biomarkers of infectious disease. Front Immunol (2017) 8:118. doi:10.3389/fimmu.2017.00118
9. Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods (2014) 11:809-15. doi:10.1038/nmeth.3014
10. Kuhn M, WingS J, Weston S, Williams A, Keefer C, Engelhardtet A, et al. Caret: Classification and Regression Training. R Package Version 6.0-71. (2016). Available from: https://CRAN.R-project.org/package=caret (Accessed: March 2, 2018)
11. Liaw A, Wiener M. Classification and regression by random forest. R News (2002) 2:18-22
12. Karatzoglou A, Smola A, Hornik K, Zeileis A. kernlab-an S4 package for kernel methods in R. J Stat Softw (2004) 11:1-20. doi:10.18637/jss.v011.i09
13. Venables WN, Ripley BD. Modern Applied Statistics with S. New York: Springer (2002)
14. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw (2010) 33:1-22. doi:10.18637/jss.v033.i01
15. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics (2011) 12:77. doi:10.1186/1471-2105-12-77
16. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag (2009)
17. Demler OV, Pencina MJ, D'agostino RB Sr. Misuse of DeLong test to compare AUCs for nested models. Stat Med (2012) 31:2577-87. doi:10.1002/sim.5328
18. Pepe MS, Kerr KF, Longton G, Wang Z. Testing for improvement in prediction model performance. Stat Med (2013) 32:1467-82. doi:10.1002/sim.5727
19. DeLong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 44:837-45. doi:10.2307/2531595
20. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis (2006) 10:1192-204
21. Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, Ferguson B, et al. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med (2012) 18:267-73. doi:10.1038/nm.2584
22. Wu Z, Lu H, Sheng J, Li L. Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2. FEBS Lett (2012) 586:2459-67. doi:10.1016/j.febslet.2012.06.004
23. Ni B, Rajaram MV, Lafuse WP, Landes MB, Schlesinger LS. Mycobacterium tuberculosis decreases human macrophage IFN-gamma responsiveness through miR-132 and miR-26a. J Immunol (2014) 193:4537-47. doi:10.4049/jimmunol.1400124
24. Sheedy FJ. Turning 21: induction of miR-21 as a key switch in the inflammatory response. Front Immunol (2015) 6:19. doi:10.3389/fimmu.2015.00019
25. Naqvi AR, Fordham JB, Nares S. MicroRNA target Fc receptors to regulate Ab-dependent Ag uptake in primary macrophages and dendritic cells. Innate Immun (2016) 22:510-21. doi:10.1177/1753425916661042
26. Zak D, Scriba TJ, Hatherill M, Penn-Nicholson A, Hanekom W. Predicting tuberculosis risk-authors' reply. Lancet (2016) 388:2233-4. doi:10.1016/S0140-6736(16)32070-0
27. Thompson EG, Du Y, Malherbe ST, Shankar S, Braun J, Valvo J, et al. Host blood RNA signatures predict the outcome of tuberculosis treatment. Tuberculosis (Edinb) (2017) 107:48-58. doi:10.1016/j.tube.2017.08.004